Allelica, a leader in genomic risk assessment for common diseases, announced today that polygenic risk scores (PRS) have been recognized as a risk-enhancing factor in the 2026 American College of ...
The 15-year data help support the idea that each test can aid in putting the other’s results in perspective, but questions ...
The PROMISE minimal risk score identifies patients with recent-onset stable chest pain who can safely avoid extra testing and are less likely to have significant coronary disease or adverse events.
The U.S. Department of Veterans Affairs (VA) has partnered with the leaders in precision medicine at Allelica to perform a clinical genomics study aimed at reducing cardiovascular risk in veterans.
Somerville, Mass.-based Mass General Brigham researchers have developed a genetic risk score to identify individuals with a greater risk of coronary artery disease. The findings were published Feb. 26 ...
The new guidelines aim to give doctors and their patients an individualized and clear path to follow. Heart disease remains the leading cause of death worldwide, according to the ...
A version of the MESA heart disease risk score that did not include race predicted heart disease risk just as well as the version that includes race, according to a preliminary study presented today ...
Heart disease remains one of the leading causes of death worldwide. Traditionally, many patients begin treatment only after experiencing a cardiovascular event. However, experts at the University of ...
Many experts consider the new online calculator a promising addition to the repertoire of tools available to help prevent heart disease. It’s meant to inspire conversations with clinicians, not ...
When it comes to heart health, prevention is the name of the game. Cardiovascular disease, heart attacks and strokes are more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results